In January 2026, the Belfast-based healthcare technology pioneer Eolas Medical secured $12 million in a Series A funding round. The investment was led by F-Prime Capital and Northzone, with participation from Octopus Ventures and several prominent angel investors from the European medical community.
The company is led by Co-Founder and CEO Dr. Declan Kelly, an emergency medicine physician who witnessed firsthand the inefficiency of accessing clinical guidelines during critical care. Eolas Medical is building an AI-powered knowledge platform that consolidates fragmented medical resources—including local hospital protocols, national guidelines, and research papers—into an intuitive, searchable digital interface for clinicians.
Healthcare professionals are currently overwhelmed by administrative fragmentation and “information rot,” where printed protocols quickly become obsolete. Eolas addresses this by using AI to curate, update, and surface the right clinical data at the point of care. This focus on specialized knowledge distribution mirrors the shift toward AI-driven clinical coaching, where high-fidelity medical logic is delivered in real-time.
The new capital will be used to scale its presence in the US market and further develop its AI features, including automated summarization of clinical evidence and predictive staffing insights. By enforcing systemic clinical guardrails, Eolas provides a level of operational reliability similar to AI-leveraged pediatric therapy platforms, ensuring that medical decisions are grounded in the most current and verified data.
Market Signal
- The “Clinical OS” Alpha: Eolas’s $12M round validates that the future of hospital efficiency lies in “Searchable Intelligence.” By replacing outdated PDF manuals with a dynamic AI layer, the company is effectively becoming the digital nervous system for frontline medical staff, a move that reduces diagnostic errors and speeds up treatment cycles.
- Founder-Physician Fit: Dr. Declan Kelly’s background as an ER doctor gives Eolas the domain authority required to bridge the gap between complex medical workflows and software engineering. This “By Doctors, For Doctors” pedigree is why F-Prime Capital—a healthcare-specialist VC—led the round.
- Scaling Quality of Care: As health systems face global nursing and physician shortages, tools that reduce “cognitive load” are becoming essential infrastructure. Eolas is transforming clinical knowledge from a static asset into a streaming utility, enabling teams to maintain peak performance even under extreme operational pressure.
Key Details
- Company: Eolas Medical
- Funding: $12M Series A
- Headquarters: Belfast, UK
- Lead Investors: F-Prime Capital, Northzone
- CEO: Dr. Declan Kelly
- Use Case: AI-powered clinical knowledge sharing, real-time medical guideline access, and hospital workflow automation
